{"id":92608,"date":"2024-02-05T10:13:39","date_gmt":"2024-02-05T09:13:39","guid":{"rendered":"https:\/\/www.pcb.ub.edu\/genesis-tech-transfer-boost-incorpora-un-nuevo-socio-y-cierra-su-tercera-inversion\/"},"modified":"2025-10-13T15:12:03","modified_gmt":"2025-10-13T13:12:03","slug":"genesis-tech-transfer-boost-incorpora-un-nuevo-socio-y-cierra-su-tercera-inversion","status":"publish","type":"post","link":"https:\/\/www.pcb.ub.edu\/es\/genesis-tech-transfer-boost-incorpora-un-nuevo-socio-y-cierra-su-tercera-inversion\/","title":{"rendered":"GENESIS Tech Transfer Boost incorpora un nuevo socio y cierra su tercera inversi\u00f3n"},"content":{"rendered":"<p><strong><a href=\"https:\/\/genesis-biomed.com\/es\/genesis-tech-transfer-boost\/\" target=\"_blank\" rel=\"noopener\"><span lang=\"EN-GB\" data-contrast=\"none\">GENESIS Tech Transfer Boost<\/span><\/a><span lang=\"EN-GB\" data-contrast=\"auto\">, <\/span>el veh\u00edculo de inversi\u00f3n gestionado por <a href=\"https:\/\/www.pcb.ub.edu\/es\/empresa\/genesis-biomed\/\" target=\"_blank\" rel=\"noopener\">GENESIS Biomed<\/a>, con sedeen el Parque Cient\u00edfico de Barcelona, incorpora un nuevo socio. El fondo se cre\u00f3 en abril de 2022 con el objetivo de detectar e invertir en proyectos en fase inicial en el sector biom\u00e9dico, provenientes de hospitales o centros acad\u00e9micos, siguiendo los pasos de su predecesor <span lang=\"CA-ES\" data-contrast=\"auto\"><a href=\"https:\/\/genesis-biomed.com\/es\/genesis-ventures\/\" target=\"_blank\" rel=\"noreferrer noopener\">GENESIS Ventures<\/a><\/span>. A la contribuci\u00f3n de 1 mill\u00f3n de euros de los socios fundadores -GENESIS Biomed, FIN Group y Crowd4Ventures- ahora se a\u00f1ade PINONO S.L. con una contribuci\u00f3n de 200.000 euros.<\/strong><\/p>\n<p>Esta nueva incorporaci\u00f3n permitir\u00e1 ampliar el n\u00famero de proyectos en los que invertir consolidando a GENESIS Tech Transfer Boost como actor relevante en la financiaci\u00f3n privada de proyectos early-stage en fase embrionaria.<\/p>\n<p>En palabras de <strong>Lian Marin\u00e9<\/strong>, socio mayoritario de PINONO: \u201cEstamos encantados de ser socio inversor de un veh\u00edculo en el \u00e1mbito de la biomedicina, como GENESIS Tech Transfer Boost. Este \u00e1mbito, que hace unos a\u00f1os resultaba desconocido para la mayor parte de los inversores, se est\u00e1 convirtiendo en un sector atractivo donde la irrupci\u00f3n del &#8216;deep tech&#8217; y las nuevas tecnolog\u00edas est\u00e1n suponiendo una revoluci\u00f3n con un elevado impacto para la calidad de vida de las personas\u201d.<\/p>\n<p>Seg\u00fan <strong>Josep Llu\u00eds Falc\u00f3<\/strong>, administrador de GENESIS Tech Transfer Boost y cofundador y CEO de GENESIS Biomed: \u00abLa incorporaci\u00f3n de un nuevo socio es una buena noticia para el veh\u00edculo, en particular, y para el ecosistema de la Biomedicina en general. La ampliaci\u00f3n del fondo permitir\u00e1 ampliar el n\u00famero de proyectos early en los que invertir. Esta inversi\u00f3n permitir\u00e1 la maduraci\u00f3n de los proyectos para poder acceder en el futuro a inversiones de capital riesgo que les permita llegar al mercado\u201d.<\/p>\n<p>El veh\u00edculo invierte tickets de entre 25.000 y 100.000\u20ac seg\u00fan la naturaleza de cada proyecto y de sus necesidades, y contempla incluso la posibilidad de invertir en fase pre-constitutiva de los proyectos. El objetivo del fondo es, en una primera fase, continuar realizando, durante los pr\u00f3ximos tres a\u00f1os, inversiones en proyectos en biomedicina para m\u00e1s adelante, en una segunda fase, encontrar escenarios de salida que permitan la recuperaci\u00f3n de la inversi\u00f3n con sus correspondientes m\u00faltiplos.<\/p>\n<p>Durante el a\u00f1o 2023 GENESIS Tech transfer Boost llev\u00f3 a cabo dos inversiones. La primera la realiz\u00f3 en marzo con la inversi\u00f3n de un ticket de 100.000 \u20ac en la spin-off del IiSPV, RetinaReadRisk, que ha desarrollado un sistema m\u00f3vil basado en inteligencia artificial para pronosticar retinopat\u00eda diab\u00e9tica. En esta spin-off GENESIS Biomed ha actuado como plataforma de <em>venture building<\/em>: adem\u00e1s de ejercer como inversor y de gestor del fondo, estuvo asumiendo \u00a0las funciones de administrador y CEO interino de la empresa, contribuyendo a captar nuevos fondos p\u00fablicos y coordinando el desarrollo regulatorio del producto, e identificando al nuevo CEO contratado recientemente en la compa\u00f1\u00eda<\/p>\n<p>La segunda inversi\u00f3n la realiz\u00f3 en abril, donde invirti\u00f3 un ticket de 25.000 \u20ac en la biotecnol\u00f3gica Spinally Medical, una empresa que ha ideado y protegido un sistema de estimulaci\u00f3n medular, para el tratamiento del dolor lumbar (Low back and legs pain-LBP).<\/p>\n<h3><strong>Primera inversi\u00f3n de 2024: Affirma Biotech<\/strong><\/h3>\n<p>Este mes de febrero, GENESIS Tech Transfer Boost ha hecho su <a href=\"https:\/\/genesis-biomed.com\/es\/genesis-tech-transfer-boost-invierte-50-000e-en-la-start-up-affirma-biotech\/\" target=\"_blank\" rel=\"noopener\">tercera inversi\u00f3n<\/a> por un ticket de 50.000 \u20ac en la biotecnol\u00f3gica <a href=\"https:\/\/www.affirmabio.com\/es\/\" target=\"_blank\" rel=\"noopener\">Affirma Biotech<\/a>, fundada en 2020 por<strong> Maribel Berges<\/strong> y centrada en el desarrollo de nuevos f\u00e1rmacos inmunoestimuladores de amplio espectro para el tratamiento de infecciones graves y c\u00e1ncer.<\/p>\n<p>La aplicaci\u00f3n de este mecanismo biol\u00f3gico, que en su momento supuso una aut\u00e9ntica revoluci\u00f3n en su aplicaci\u00f3n a tratamientos de inmunooncolog\u00eda, no se ha explorado hasta el momento al \u00e1mbito de las enfermedades infecciosas, donde podr\u00eda aportar avances relevantes para la mejora de la salud global.<\/p>\n<p>Este ticket de GENESIS Tech Transfer Boost se enmarca dentro del cierre de una ronda de inversi\u00f3n -liderada por Nara Capital y los actuales socios de Affirma- a la que se unen otras ayudas p\u00fablicas -procedentes del CDTI (Programa Neotec) y de la Agencia Estatal de Investigaci\u00f3n (Convocatoria de ayudas a proyectos de colaboraci\u00f3n p\u00fablico-privada)- que elevan a 1,75 M \u20ac el capital levantado por la biotech a principios de este 2024.<\/p>\n<p>Para <strong>Josep Llu\u00eds Falc\u00f3<\/strong>, \u201cAffirma representa una gran apuesta para nuestro portafolio de compa\u00f1\u00edas participadas, desarrollando nuevos medicamentos para estimular el sistema inmunitario en el tratamiento de infecciones virales y bacterianas. La participaci\u00f3n de Nara capital y de relevantes inversores del sector farmac\u00e9utico, pone de relieve el potencial de la inmunoterapia que se extiende del \u00e1rea oncol\u00f3gica hacia otras \u00e1reas, como la de las enfermedades infecciosas. Estamos seguros de que un futuro prometedor se abre en este campo\u00bb.<\/p>\n<p>\u00bb M\u00e1s informaci\u00f3n: <a href=\"https:\/\/genesis-biomed.com\/es\/sala-de-prensa\/noticias\/\" target=\"_blank\" rel=\"noopener\">web de GENESIS Biomed [+]<\/a><\/p>\n<p>&nbsp;<\/p>\n<p>&nbsp;<\/p>\n<p>&nbsp;<\/p>\n<p>&nbsp;<\/p>\n","protected":false},"excerpt":{"rendered":"<p>GENESIS Tech Transfer Boost, el veh\u00edculo de inversi\u00f3n gestionado por GENESIS Biomed, con sedeen el Parque Cient\u00edfico de Barcelona, incorpora un nuevo socio. El fondo se cre\u00f3 en abril de&#8230;<\/p>\n","protected":false},"author":14,"featured_media":92614,"comment_status":"closed","ping_status":"closed","sticky":false,"template":"","format":"standard","meta":{"_acf_changed":false,"inline_featured_image":false,"footnotes":""},"categories":[356],"tags":[],"class_list":["post-92608","post","type-post","status-publish","format-standard","has-post-thumbnail","category-empresas"],"acf":[],"yoast_head":"<!-- This site is optimized with the Yoast SEO plugin v28.4 - https:\/\/yoast.com\/product\/yoast-seo-wordpress\/ -->\n<title>GENESIS Tech Transfer Boost incorpora un nuevo socio y cierra su tercera inversi\u00f3n - Parc Cient\u00edfic de Barcelona<\/title>\n<meta name=\"robots\" content=\"index, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<link rel=\"canonical\" href=\"https:\/\/www.pcb.ub.edu\/es\/genesis-tech-transfer-boost-incorpora-un-nuevo-socio-y-cierra-su-tercera-inversion\/\" \/>\n<meta property=\"og:locale\" content=\"es_ES\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"GENESIS Tech Transfer Boost incorpora un nuevo socio y cierra su tercera inversi\u00f3n - Parc Cient\u00edfic de Barcelona\" \/>\n<meta property=\"og:description\" content=\"GENESIS Tech Transfer Boost, el veh\u00edculo de inversi\u00f3n gestionado por GENESIS Biomed, con sedeen el Parque Cient\u00edfico de Barcelona, incorpora un nuevo socio. El fondo se cre\u00f3 en abril de...\" \/>\n<meta property=\"og:url\" content=\"https:\/\/www.pcb.ub.edu\/es\/genesis-tech-transfer-boost-incorpora-un-nuevo-socio-y-cierra-su-tercera-inversion\/\" \/>\n<meta property=\"og:site_name\" content=\"Parc Cient\u00edfic de Barcelona\" \/>\n<meta property=\"article:published_time\" content=\"2024-02-05T09:13:39+00:00\" \/>\n<meta property=\"article:modified_time\" content=\"2025-10-13T13:12:03+00:00\" \/>\n<meta property=\"og:image\" content=\"https:\/\/www.pcb.ub.edu\/wp-content\/uploads\/2024\/02\/genesis_biomed_team-2023-1.png\" \/>\n\t<meta property=\"og:image:width\" content=\"1238\" \/>\n\t<meta property=\"og:image:height\" content=\"454\" \/>\n\t<meta property=\"og:image:type\" content=\"image\/png\" \/>\n<meta name=\"author\" content=\"Paula Ca\u00f1al\" \/>\n<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\n<meta name=\"twitter:label1\" content=\"Escrito por\" \/>\n\t<meta name=\"twitter:data1\" content=\"Paula Ca\u00f1al\" \/>\n\t<meta name=\"twitter:label2\" content=\"Tiempo de lectura\" \/>\n\t<meta name=\"twitter:data2\" content=\"4 minutos\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\\\/\\\/schema.org\",\"@graph\":[{\"@type\":\"Article\",\"@id\":\"https:\\\/\\\/www.pcb.ub.edu\\\/es\\\/genesis-tech-transfer-boost-incorpora-un-nuevo-socio-y-cierra-su-tercera-inversion\\\/#article\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/www.pcb.ub.edu\\\/es\\\/genesis-tech-transfer-boost-incorpora-un-nuevo-socio-y-cierra-su-tercera-inversion\\\/\"},\"author\":{\"name\":\"Paula Ca\u00f1al\",\"@id\":\"https:\\\/\\\/www.pcb.ub.edu\\\/es\\\/#\\\/schema\\\/person\\\/dece7d71551633ff3423502f3e384c6a\"},\"headline\":\"GENESIS Tech Transfer Boost incorpora un nuevo socio y cierra su tercera inversi\u00f3n\",\"datePublished\":\"2024-02-05T09:13:39+00:00\",\"dateModified\":\"2025-10-13T13:12:03+00:00\",\"mainEntityOfPage\":{\"@id\":\"https:\\\/\\\/www.pcb.ub.edu\\\/es\\\/genesis-tech-transfer-boost-incorpora-un-nuevo-socio-y-cierra-su-tercera-inversion\\\/\"},\"wordCount\":833,\"image\":{\"@id\":\"https:\\\/\\\/www.pcb.ub.edu\\\/es\\\/genesis-tech-transfer-boost-incorpora-un-nuevo-socio-y-cierra-su-tercera-inversion\\\/#primaryimage\"},\"thumbnailUrl\":\"https:\\\/\\\/www.pcb.ub.edu\\\/wp-content\\\/uploads\\\/2024\\\/02\\\/genesis_biomed_team-2023-1.png\",\"articleSection\":[\"EMPRESAS\"],\"inLanguage\":\"es\"},{\"@type\":\"WebPage\",\"@id\":\"https:\\\/\\\/www.pcb.ub.edu\\\/es\\\/genesis-tech-transfer-boost-incorpora-un-nuevo-socio-y-cierra-su-tercera-inversion\\\/\",\"url\":\"https:\\\/\\\/www.pcb.ub.edu\\\/es\\\/genesis-tech-transfer-boost-incorpora-un-nuevo-socio-y-cierra-su-tercera-inversion\\\/\",\"name\":\"GENESIS Tech Transfer Boost incorpora un nuevo socio y cierra su tercera inversi\u00f3n - Parc Cient\u00edfic de Barcelona\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/www.pcb.ub.edu\\\/es\\\/#website\"},\"primaryImageOfPage\":{\"@id\":\"https:\\\/\\\/www.pcb.ub.edu\\\/es\\\/genesis-tech-transfer-boost-incorpora-un-nuevo-socio-y-cierra-su-tercera-inversion\\\/#primaryimage\"},\"image\":{\"@id\":\"https:\\\/\\\/www.pcb.ub.edu\\\/es\\\/genesis-tech-transfer-boost-incorpora-un-nuevo-socio-y-cierra-su-tercera-inversion\\\/#primaryimage\"},\"thumbnailUrl\":\"https:\\\/\\\/www.pcb.ub.edu\\\/wp-content\\\/uploads\\\/2024\\\/02\\\/genesis_biomed_team-2023-1.png\",\"datePublished\":\"2024-02-05T09:13:39+00:00\",\"dateModified\":\"2025-10-13T13:12:03+00:00\",\"author\":{\"@id\":\"https:\\\/\\\/www.pcb.ub.edu\\\/es\\\/#\\\/schema\\\/person\\\/dece7d71551633ff3423502f3e384c6a\"},\"breadcrumb\":{\"@id\":\"https:\\\/\\\/www.pcb.ub.edu\\\/es\\\/genesis-tech-transfer-boost-incorpora-un-nuevo-socio-y-cierra-su-tercera-inversion\\\/#breadcrumb\"},\"inLanguage\":\"es\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"https:\\\/\\\/www.pcb.ub.edu\\\/es\\\/genesis-tech-transfer-boost-incorpora-un-nuevo-socio-y-cierra-su-tercera-inversion\\\/\"]}]},{\"@type\":\"ImageObject\",\"inLanguage\":\"es\",\"@id\":\"https:\\\/\\\/www.pcb.ub.edu\\\/es\\\/genesis-tech-transfer-boost-incorpora-un-nuevo-socio-y-cierra-su-tercera-inversion\\\/#primaryimage\",\"url\":\"https:\\\/\\\/www.pcb.ub.edu\\\/wp-content\\\/uploads\\\/2024\\\/02\\\/genesis_biomed_team-2023-1.png\",\"contentUrl\":\"https:\\\/\\\/www.pcb.ub.edu\\\/wp-content\\\/uploads\\\/2024\\\/02\\\/genesis_biomed_team-2023-1.png\",\"width\":1238,\"height\":454},{\"@type\":\"BreadcrumbList\",\"@id\":\"https:\\\/\\\/www.pcb.ub.edu\\\/es\\\/genesis-tech-transfer-boost-incorpora-un-nuevo-socio-y-cierra-su-tercera-inversion\\\/#breadcrumb\",\"itemListElement\":[{\"@type\":\"ListItem\",\"position\":1,\"name\":\"Home\",\"item\":\"https:\\\/\\\/www.pcb.ub.edu\\\/es\\\/\"},{\"@type\":\"ListItem\",\"position\":2,\"name\":\"GENESIS Tech Transfer Boost incorpora un nuevo socio y cierra su tercera inversi\u00f3n\"}]},{\"@type\":\"WebSite\",\"@id\":\"https:\\\/\\\/www.pcb.ub.edu\\\/es\\\/#website\",\"url\":\"https:\\\/\\\/www.pcb.ub.edu\\\/es\\\/\",\"name\":\"Parc Cient\u00edfic de Barcelona\",\"description\":\"Universitat de Barcelona\",\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"https:\\\/\\\/www.pcb.ub.edu\\\/es\\\/?s={search_term_string}\"},\"query-input\":{\"@type\":\"PropertyValueSpecification\",\"valueRequired\":true,\"valueName\":\"search_term_string\"}}],\"inLanguage\":\"es\"},{\"@type\":\"Person\",\"@id\":\"https:\\\/\\\/www.pcb.ub.edu\\\/es\\\/#\\\/schema\\\/person\\\/dece7d71551633ff3423502f3e384c6a\",\"name\":\"Paula Ca\u00f1al\",\"image\":{\"@type\":\"ImageObject\",\"inLanguage\":\"es\",\"@id\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/b994665ec600f20526048e5d98eab6b8aa5e116b6fe2101daebcb986872bd355?s=96&d=mm&r=g\",\"url\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/b994665ec600f20526048e5d98eab6b8aa5e116b6fe2101daebcb986872bd355?s=96&d=mm&r=g\",\"contentUrl\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/b994665ec600f20526048e5d98eab6b8aa5e116b6fe2101daebcb986872bd355?s=96&d=mm&r=g\",\"caption\":\"Paula Ca\u00f1al\"},\"url\":\"https:\\\/\\\/www.pcb.ub.edu\\\/es\\\/author\\\/paula\\\/\"}]}<\/script>\n<!-- \/ Yoast SEO plugin. -->","yoast_head_json":{"title":"GENESIS Tech Transfer Boost incorpora un nuevo socio y cierra su tercera inversi\u00f3n - Parc Cient\u00edfic de Barcelona","robots":{"index":"index","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"canonical":"https:\/\/www.pcb.ub.edu\/es\/genesis-tech-transfer-boost-incorpora-un-nuevo-socio-y-cierra-su-tercera-inversion\/","og_locale":"es_ES","og_type":"article","og_title":"GENESIS Tech Transfer Boost incorpora un nuevo socio y cierra su tercera inversi\u00f3n - Parc Cient\u00edfic de Barcelona","og_description":"GENESIS Tech Transfer Boost, el veh\u00edculo de inversi\u00f3n gestionado por GENESIS Biomed, con sedeen el Parque Cient\u00edfico de Barcelona, incorpora un nuevo socio. El fondo se cre\u00f3 en abril de...","og_url":"https:\/\/www.pcb.ub.edu\/es\/genesis-tech-transfer-boost-incorpora-un-nuevo-socio-y-cierra-su-tercera-inversion\/","og_site_name":"Parc Cient\u00edfic de Barcelona","article_published_time":"2024-02-05T09:13:39+00:00","article_modified_time":"2025-10-13T13:12:03+00:00","og_image":[{"width":1238,"height":454,"url":"https:\/\/www.pcb.ub.edu\/wp-content\/uploads\/2024\/02\/genesis_biomed_team-2023-1.png","type":"image\/png"}],"author":"Paula Ca\u00f1al","twitter_card":"summary_large_image","twitter_misc":{"Escrito por":"Paula Ca\u00f1al","Tiempo de lectura":"4 minutos"},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"Article","@id":"https:\/\/www.pcb.ub.edu\/es\/genesis-tech-transfer-boost-incorpora-un-nuevo-socio-y-cierra-su-tercera-inversion\/#article","isPartOf":{"@id":"https:\/\/www.pcb.ub.edu\/es\/genesis-tech-transfer-boost-incorpora-un-nuevo-socio-y-cierra-su-tercera-inversion\/"},"author":{"name":"Paula Ca\u00f1al","@id":"https:\/\/www.pcb.ub.edu\/es\/#\/schema\/person\/dece7d71551633ff3423502f3e384c6a"},"headline":"GENESIS Tech Transfer Boost incorpora un nuevo socio y cierra su tercera inversi\u00f3n","datePublished":"2024-02-05T09:13:39+00:00","dateModified":"2025-10-13T13:12:03+00:00","mainEntityOfPage":{"@id":"https:\/\/www.pcb.ub.edu\/es\/genesis-tech-transfer-boost-incorpora-un-nuevo-socio-y-cierra-su-tercera-inversion\/"},"wordCount":833,"image":{"@id":"https:\/\/www.pcb.ub.edu\/es\/genesis-tech-transfer-boost-incorpora-un-nuevo-socio-y-cierra-su-tercera-inversion\/#primaryimage"},"thumbnailUrl":"https:\/\/www.pcb.ub.edu\/wp-content\/uploads\/2024\/02\/genesis_biomed_team-2023-1.png","articleSection":["EMPRESAS"],"inLanguage":"es"},{"@type":"WebPage","@id":"https:\/\/www.pcb.ub.edu\/es\/genesis-tech-transfer-boost-incorpora-un-nuevo-socio-y-cierra-su-tercera-inversion\/","url":"https:\/\/www.pcb.ub.edu\/es\/genesis-tech-transfer-boost-incorpora-un-nuevo-socio-y-cierra-su-tercera-inversion\/","name":"GENESIS Tech Transfer Boost incorpora un nuevo socio y cierra su tercera inversi\u00f3n - Parc Cient\u00edfic de Barcelona","isPartOf":{"@id":"https:\/\/www.pcb.ub.edu\/es\/#website"},"primaryImageOfPage":{"@id":"https:\/\/www.pcb.ub.edu\/es\/genesis-tech-transfer-boost-incorpora-un-nuevo-socio-y-cierra-su-tercera-inversion\/#primaryimage"},"image":{"@id":"https:\/\/www.pcb.ub.edu\/es\/genesis-tech-transfer-boost-incorpora-un-nuevo-socio-y-cierra-su-tercera-inversion\/#primaryimage"},"thumbnailUrl":"https:\/\/www.pcb.ub.edu\/wp-content\/uploads\/2024\/02\/genesis_biomed_team-2023-1.png","datePublished":"2024-02-05T09:13:39+00:00","dateModified":"2025-10-13T13:12:03+00:00","author":{"@id":"https:\/\/www.pcb.ub.edu\/es\/#\/schema\/person\/dece7d71551633ff3423502f3e384c6a"},"breadcrumb":{"@id":"https:\/\/www.pcb.ub.edu\/es\/genesis-tech-transfer-boost-incorpora-un-nuevo-socio-y-cierra-su-tercera-inversion\/#breadcrumb"},"inLanguage":"es","potentialAction":[{"@type":"ReadAction","target":["https:\/\/www.pcb.ub.edu\/es\/genesis-tech-transfer-boost-incorpora-un-nuevo-socio-y-cierra-su-tercera-inversion\/"]}]},{"@type":"ImageObject","inLanguage":"es","@id":"https:\/\/www.pcb.ub.edu\/es\/genesis-tech-transfer-boost-incorpora-un-nuevo-socio-y-cierra-su-tercera-inversion\/#primaryimage","url":"https:\/\/www.pcb.ub.edu\/wp-content\/uploads\/2024\/02\/genesis_biomed_team-2023-1.png","contentUrl":"https:\/\/www.pcb.ub.edu\/wp-content\/uploads\/2024\/02\/genesis_biomed_team-2023-1.png","width":1238,"height":454},{"@type":"BreadcrumbList","@id":"https:\/\/www.pcb.ub.edu\/es\/genesis-tech-transfer-boost-incorpora-un-nuevo-socio-y-cierra-su-tercera-inversion\/#breadcrumb","itemListElement":[{"@type":"ListItem","position":1,"name":"Home","item":"https:\/\/www.pcb.ub.edu\/es\/"},{"@type":"ListItem","position":2,"name":"GENESIS Tech Transfer Boost incorpora un nuevo socio y cierra su tercera inversi\u00f3n"}]},{"@type":"WebSite","@id":"https:\/\/www.pcb.ub.edu\/es\/#website","url":"https:\/\/www.pcb.ub.edu\/es\/","name":"Parc Cient\u00edfic de Barcelona","description":"Universitat de Barcelona","potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/www.pcb.ub.edu\/es\/?s={search_term_string}"},"query-input":{"@type":"PropertyValueSpecification","valueRequired":true,"valueName":"search_term_string"}}],"inLanguage":"es"},{"@type":"Person","@id":"https:\/\/www.pcb.ub.edu\/es\/#\/schema\/person\/dece7d71551633ff3423502f3e384c6a","name":"Paula Ca\u00f1al","image":{"@type":"ImageObject","inLanguage":"es","@id":"https:\/\/secure.gravatar.com\/avatar\/b994665ec600f20526048e5d98eab6b8aa5e116b6fe2101daebcb986872bd355?s=96&d=mm&r=g","url":"https:\/\/secure.gravatar.com\/avatar\/b994665ec600f20526048e5d98eab6b8aa5e116b6fe2101daebcb986872bd355?s=96&d=mm&r=g","contentUrl":"https:\/\/secure.gravatar.com\/avatar\/b994665ec600f20526048e5d98eab6b8aa5e116b6fe2101daebcb986872bd355?s=96&d=mm&r=g","caption":"Paula Ca\u00f1al"},"url":"https:\/\/www.pcb.ub.edu\/es\/author\/paula\/"}]}},"_links":{"self":[{"href":"https:\/\/www.pcb.ub.edu\/es\/wp-json\/wp\/v2\/posts\/92608","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/www.pcb.ub.edu\/es\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/www.pcb.ub.edu\/es\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/www.pcb.ub.edu\/es\/wp-json\/wp\/v2\/users\/14"}],"replies":[{"embeddable":true,"href":"https:\/\/www.pcb.ub.edu\/es\/wp-json\/wp\/v2\/comments?post=92608"}],"version-history":[{"count":6,"href":"https:\/\/www.pcb.ub.edu\/es\/wp-json\/wp\/v2\/posts\/92608\/revisions"}],"predecessor-version":[{"id":92623,"href":"https:\/\/www.pcb.ub.edu\/es\/wp-json\/wp\/v2\/posts\/92608\/revisions\/92623"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/www.pcb.ub.edu\/es\/wp-json\/wp\/v2\/media\/92614"}],"wp:attachment":[{"href":"https:\/\/www.pcb.ub.edu\/es\/wp-json\/wp\/v2\/media?parent=92608"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/www.pcb.ub.edu\/es\/wp-json\/wp\/v2\/categories?post=92608"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/www.pcb.ub.edu\/es\/wp-json\/wp\/v2\/tags?post=92608"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}